Shares of Akerna (NASDAQ:KERN) traded up 8.8% during trading on Thursday . The stock traded as high as $4.58 and last traded at $3.96. 763,700 shares changed hands during mid-day trading, an increase of 508% from the average session volume of 125,610 shares. The stock had previously closed at $3.64.
Separately, ValuEngine raised Akerna from a “hold” rating to a “buy” rating in a research report on Friday, June 19th.
The stock has a 50-day moving average of $5.07 and a 200 day moving average of $6.91.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. UBS Group AG lifted its holdings in shares of Akerna by 6,033.9% during the 2nd quarter. UBS Group AG now owns 3,435 shares of the company’s stock valued at $30,000 after buying an additional 3,379 shares during the period. American International Group Inc. bought a new stake in shares of Akerna during the second quarter valued at approximately $48,000. Bank of America Corp DE raised its stake in shares of Akerna by 2,501.6% during the second quarter. Bank of America Corp DE now owns 6,426 shares of the company’s stock valued at $57,000 after acquiring an additional 6,179 shares in the last quarter. New York State Common Retirement Fund bought a new stake in shares of Akerna during the second quarter valued at approximately $94,000. Finally, Jane Street Group LLC bought a new stake in shares of Akerna during the second quarter valued at approximately $126,000. 10.15% of the stock is owned by institutional investors.
Akerna Company Profile (NASDAQ:KERN)
Akerna Corp. operates a technology company in the cannabis space. The company offers MJ Platform and Leaf Data Systems that provide clients and government entities with a central data management system for tracking regulated cannabis products. Akerna Corp. was founded in 2010 and is based in Denver, Colorado.
Featured Story: Growth Stocks
Receive News & Ratings for Akerna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akerna and related companies with MarketBeat.com's FREE daily email newsletter.